Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GE Taps Healthcare Again For New Group Head

Executive Summary

GE Healthcare CEO John Flannery is taking over from Jeff Immelt as head of GE and replacing Flannery is Kieran Murphy. Current GE CFO Jeff Bornstein has also been promoted to vice-chair.

You may also be interested in...

Medtech's High-Earners: 2016 Executive Payouts Boosted By Bonuses, Stock Awards

A Medtech Insight analysis of the highest-earning CEOs among the top medtech companies in last year's MTI 100 company league table shows that these individuals benefited mainly from stock and options holdings, as well as very generous incentive bonuses, bestowed upon them by their boards of directors. However, a couple of CEOs, including Zimmer Biomet's David Dvorak and Cardinal Health's George Barrett, who were rewarded fiscally for taking their companies to growth have had their leadership challenged since then.

President Trump Disbands Business Advisory Councils

J&J and GE were among firms represented on the Trump administration's manufacturing council, one of two business advisory groups that were dissolved on Aug. 16 after a growing number of executives walked away from the endeavors in the wake of Trump's remarks regarding white nationalist demonstrations in Virginia.

Estrampes Appointed To Helm Of GE Healthcare EU

GE Healthcare has appointed Catherine Estrampes as CEO of its European operations, replacing Jean-Michel Malbrancq who is leaving to pursue opportunities outside of GE after 35 years with the company.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts